Medgend Icon

Ledgend of Medicine







discontinued


Oxaliplatin FDA Approved Drugs

ELOXATIN [OxaliplatinC6H14N2C2O4Pt]
RX
-
100mg/20ml (5mg/ml) (iv (infusion) injectable)
50mg/10ml (5mg/ml) (iv (infusion) injectable)
Sanofi Aventis UsJan 31, 2005
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LONSURF [Tipiracil HydrochlorideC9H11ClN4O2ClH : TrifluridineC10H11F3N2O5]
RX
-
eq 6.14mg base : 15mg (oral tablet)
eq 8.19mg base : 20mg (oral tablet)
Taiho OncologySep 22, 2015
  • Treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf biological therapy, and if ras wild-type, an anti-egfr therapy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OXALIPLATIN [OxaliplatinC6H14N2C2O4Pt]
RX
-
100mg/20ml (5mg/ml) (iv (infusion) injectable)
100mg/vial (iv (infusion) injectable)
200mg/40ml (5mg/ml) (iv (infusion) injectable)
50mg/10ml (5mg/ml) (iv (infusion) injectable)
50mg/vial (iv (infusion) injectable)
Accord HlthcareMar 21, 2017
Cipla LtdFeb 10, 2017
Fresenius Kabi OncolJun 10, 2010
Fresenius Kabi UsaJan 31, 2017
Gland Pharma LtdFeb 10, 2017
Hospira WorldwideAug 7, 2009
Jiangsu Hengrui MedJun 18, 2014
Luitpold Pharms IncMay 12, 2017
Mylan Labs LtdAug 7, 2012
Qilu Pharm Co LtdJun 7, 2016
SandozJan 24, 2011
Sun Pharma GlobalApr 8, 2014
Teva PharmsAug 7, 2009
Actavis TotowaAug 8, 2012
Hospira IncSep 30, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.